Literature DB >> 2423278

The wasted mutant mouse. II. Immunological abnormalities in a mouse described as a model of ataxia-telangiectasia.

D Kaiserlian, W Savino, J Uriel, J Hassid, M Dardenne, J F Bach.   

Abstract

Ataxia-telangiectasia (AT) is a complex multiparametric disease associating oculocutaneous telangiectasias, cerebellar ataxia, elevated chromosomal aberration frequency and varied degrees of immunodeficiency. Recently a wasted mutant mouse (wst) has been described as an animal model of AT. We have looked in the wasted mutants for the presence of immune and endocrine abnormalities characteristic of AT. In contrast to the T cell immunodeficiency in AT, wasted mutants had a marked hypoplasia of all lymphoid organs, which affected both T and B lymphocyte subsets. The marked thymic atrophy appearing at the final stage of their disease did not modify the endocrine function of the thymic epithelium which produced normal levels of the thymic hormone thymulin. Although in vitro interleukin 2 (IL-2) production by splenic T cells in response to Con A was markedly diminished, these mice presented normal T and B cell proliferative responses to mitogens. Finally, no significant increase in serum alpha-fetoprotein level (a typical marker of AT) was found throughout the course of the disease. Although by many aspects, i.e. neurological disorder, chromosomal aberrations and early death, wasted mice presented similarities with human AT, major discrepancies in the typical features of immune abnormalities were found between the mouse model and the human disease.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2423278      PMCID: PMC1577570     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  11 in total

1.  ATAXIA-TELANGIECTASIA. ITS ASSOCIATION WITH A DEFECTIVE THYMUS, IMMUNOLOGICAL-DEFICIENCY DISEASE, AND MALIGNANCY.

Authors:  R D PETERSON; W D KELLY; R A GOOD
Journal:  Lancet       Date:  1964-05-30       Impact factor: 79.321

2.  Long term culture of tumour-specific cytotoxic T cells.

Authors:  S Gillis; K A Smith
Journal:  Nature       Date:  1977-07-14       Impact factor: 49.962

3.  Serum-alpha-fetoprotein levels in patients with ataxia-telangiectasia.

Authors:  T A Waldmann; K R McIntire
Journal:  Lancet       Date:  1972-11-25       Impact factor: 79.321

4.  Ataxia-telangiectasia.

Authors:  D E McFarlin; W Strober; T A Waldmann
Journal:  Medicine (Baltimore)       Date:  1972-07       Impact factor: 1.889

5.  Dissociated effects of thymectomy at weaning on T-cell-mediated responses in vitro: correction by the serum thymic factor, FTS, and its analogs.

Authors:  D Kaiserlian; M Dardenne; J F Bach
Journal:  Cell Immunol       Date:  1981-10       Impact factor: 4.868

6.  'Wasted', a new mutant of the mouse with abnormalities characteristic to ataxia telangiectasia.

Authors:  L D Shultz; H O Sweet; M T Davisson; D R Coman
Journal:  Nature       Date:  1982-06-03       Impact factor: 49.962

7.  Improvement of cellular immunity and IgA production in immunodeficient children after treatment with synthetic serum thymic factor (FTS).

Authors:  P Bordigoni; G Faure; M C Bene; M Dardenne; J F Bach; J Duheille; D Olive
Journal:  Lancet       Date:  1982-08-07       Impact factor: 79.321

8.  The wasted mutant mouse. I. An animal model of secretory IgA deficiency with normal serum IgA.

Authors:  D Kaiserlian; D Delacroix; J F Bach
Journal:  J Immunol       Date:  1985-08       Impact factor: 5.422

9.  Heterogeneity of immunological abnormalities in ataxia-telangiectasia.

Authors:  M Fiorilli; L Businco; F Pandolfi; R Paganelli; G Russo; F Aiuti
Journal:  J Clin Immunol       Date:  1983-04       Impact factor: 8.317

10.  Affinity chromatography of mouse alpha-fetoprotein (AFP) on oestradiol-Sepharose adsorbents--isolation and properties.

Authors:  R Hassoux; J Berges; J Uriel
Journal:  J Steroid Biochem       Date:  1977-02       Impact factor: 4.292

View more
  1 in total

1.  Absence of Rac1 and Rac3 GTPases in the nervous system hinders thymic, splenic and immune-competence development.

Authors:  Veronica Basso; Sara Corbetta; Sara Gualdoni; Diletta Tonoli; Pietro Luigi Poliani; Francesca Sanvito; Claudio Doglioni; Anna Mondino; Ivan de Curtis
Journal:  Eur J Immunol       Date:  2011-04-15       Impact factor: 5.532

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.